Prospect of Combination and Sequential Therapies for Postmenopausal Osteoporosis

E-ISSN： 1873-4286|23|41|6251-6255

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.41, 2018-02, pp. : 6251-6255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis

By Reginster Jean-Yves

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 65-78

Adis International

Access to resources Recommend Favorite

Which therapies warranted for postmenopausal osteoporosis?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Osteoporosis therapies

By Mulligan L. Grandjean N.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 755-766

Informa Healthcare

Access to resources Recommend Favorite

Denosumab delivers in postmenopausal osteoporosis

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Parathyroid hormones for postmenopausal osteoporosis

Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite